Bejar Rafael 4
4 · Aptose Biosciences Inc. · Filed Feb 7, 2024
Insider Transaction Report
Form 4
Bejar Rafael
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-02-05+35,000→ 35,000 totalExercise: $2.00Exp: 2034-02-05→ Common Shares (35,000 underlying)
Footnotes (1)
- [F1]50% of the options vest on February 5, 2025, with the remaining options vesting as follows: 1/3 on February 5, 2026; 1/3 on February 5, 2027; and 1/3 on February 5, 2028.